BSE · 507747 · Diversified
TTK Healthcare Ltd.
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹929 Cr with net profit ₹66 Cr — a 7.07% net margin, versus 9.36% the period before.
Shareholding
As of 2026-06-30
- Promoter74.56%
- Public21.39%
- FII1.86%
- DII2.19%
22,809 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 1.72× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Diversified - Medium / Small · ranked #2 of 40 by market cap · medians across 34 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Indiabulls Limited | ₹6,227 Cr | 30.38 | 1.94 | 10.93% | 33.18% |
| TTK Healthcare Ltd.(this company) | ₹1,412 Cr | 20.56 | 1.27 | 5.89% | 7.66% |
| Andrew Yule & Company Ltd. | ₹1,367 Cr | -70.21 | 4.2 | -5.9% | -6.55% |
| Kalind Limited | ₹951 Cr | 34.67 | 4.49 | 12.86% | 40.13% |
| Sobhagya Merchantile Ltd. | ₹950 Cr | 43.13 | 4.01 | 11.42% | 9.48% |
| Indo Farm Equipment Ltd. | ₹730 Cr | 83.98 | 1.31 | 4.44% | 5.61% |
| Empire Industries Ltd. | ₹616 Cr | 11.88 | 1.75 | 14.67% | 7.05% |
| Oswal Greentech Limited | ₹548 Cr | 15.36 | 0.23 | 1.49% | -118% |
| Majestic Auto Ltd. | ₹446 Cr | 20.67 | 0.67 | 3.33% | 259.02% |
| Lehar Footwears Limited | ₹432 Cr | 20.7 | 4.12 | 15.73% | 4.83% |
AI analysis
AI-generated · google/gemini-2.5-flashTTK Healthcare Ltd. operates in diversified sectors, including animal welfare, consumer products, medical devices, protective devices, food, and other businesses. The company reported a market capitalization of Rs 1436 Cr, with a PE ratio of 20.91 and an EPS of 48.6. Its revenue stands at Rs 857.28 Cr, with a profit margin of 7.66%.
Positives
- +The company has a very low debt-to-equity ratio of 0.02, indicating strong financial health.
- +Promoter holding is high at 74.56% as of June 30, 2026, indicating confidence from the promoters.
- +The company's revenue has increased from Rs 485.99 Cr in Mar 2021 to Rs 872.75 Cr in Mar 2025.
- +Net profit increased from Rs 46.44 Cr in Mar 2021 to Rs 81.66 Cr in Mar 2025.
Negatives
- −The latest reported dividend yield is 97%, which appears unusually high and may require further investigation.
- −Return on Equity (ROE) is relatively low at 5.89%.
- −Return on Capital Employed (ROCE) is 7.50%, which could be higher.
- −The profit margin is 7.66%, which may indicate limited pricing power or operational efficiency challenges.
- −The data does not provide quarterly EPS figures.
Business
TTK Healthcare Limited is engaged in multiple business segments across India. These segments include Animal Welfare, offering feed supplements and veterinary products; Consumer Products, marketing baby care, personal care, and home care items; Medical Devices, manufacturing artificial heart valves and orthopedic implants; Protective Devices, producing sexual wellness products; Foods, engaged in manufacturing and marketing food products like papads; and Others, which involves printing and publishing maps and educational materials. The company was founded in 1928 and is headquartered in Chennai, India.
Financial Performance
The company's annual revenue has shown growth over the past few years. Revenue increased from Rs 485.99 Cr in Mar 2021 to Rs 872.75 Cr in Mar 2025. Net profit also rose from Rs 46.44 Cr in Mar 2021 to Rs 81.66 Cr in Mar 2025. The EPS grew from Rs 32.87 in Mar 2021 to Rs 57.79 in Mar 2025.
Profitability & Returns
TTK Healthcare Ltd. reported a profit margin of 7.66%. The Return on Equity (ROE) for the company is 5.89%, while the Return on Capital Employed (ROCE) is 7.50%. The EPS for the latest annual period was Rs 57.79.
Balance Sheet
The company maintains a low debt-to-equity ratio of 0.02, indicating minimal reliance on debt financing. The book value per share is Rs 785.85, reflecting the company's net asset value per share.
Ownership & Pledges
Public shareholding stands at 21.39%. There are no promoter pledges reported.
Data as of — price: 2026-07-30 · financials: Mar 26 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.